Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2602-2609

  Hébrant, Aline ^a   Van Sande, Jacqueline ^a   Roger, Pierre P ^a   Patey, Martine ^b   Klein, Marc ^c   Bournaud, Claire ^d   Savagner, Frédérique ^e   Leclère, Jacques ^c   Dumont, Jacques E ^a   Van Staveren, Wilma C G ^a   Maenhaut, Carine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b SERVICE DE DERMATOLOGIE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e Universite d'Angers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; HYDROXIDE; INOSITOL PHOSPHATE; IODIDE; THYROTROPIN;

ADENOMA; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTONOMOUS ADENOMA; BIOINFORMATICS; BIOSYNTHESIS; CELL ADHESION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA FINGERPRINTING; DOWN REGULATION; EXTRACELLULAR MATRIX; FAMILIAL DISEASE; FAMILIAL NONAUTOIMMUNE HYPERTHYROIDISM; GENE CONTROL; GENE EXPRESSION; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; HYBRIDIZATION; HYPERTHYROIDISM; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO CULTURE; MICROARRAY ANALYSIS; MITOGENESIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION; THYROID CELL; THYROID GLAND; UPREGULATION;

EID: 67650257673     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2191     Document Type: Article

References (62)

1. Lania A, Mantovani G, Spada A 2001 G protein mutations in endocrine diseases. Eur J Endocrinol 145:543-559
2. Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D 2006 Congenital hyperthyroidism: the fetus as a patient. Horm Res 65:235-242
3. Dremier S, Coppee F, Delange F, Vassart G, Dumont JE, Van Sande J 1996 Clinical review 84: thyroid autonomy: mechanism and clinical effects. J Clin Endocrinol Metab 81:4187-4193
4. Wattel S, Mircescu H, Venet D, Burniat A, Franc B, Frank S, Andry G, Van Sande J, Rocmans P, Dumont JE, Detours V, Maenhaut C 2005 Gene expression in thyroid autonomous adenomas provides insight into their physiopathology. Oncogene 24:6902-6916
5. Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G, Persani L 2001 A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 145:249-254
6. Arturi F, Chiefari E, Tumino S, Russo D, Squatrito S, Chazenbalk G, Persani L, Rapoport B, Filetti S 2002 Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation. J Endocrinol Invest 25:696-701
7. Biebermann H, Schoneberg T, Krude H, Gudermann T, Gruters A 2000 Constitutively activating TSH-receptor mutations as a molecular cause of nonautoimmune hyperthyroidism in childhood. Langenbecks Arch Surg 385:390-392
8. Biebermann H, Schoneberg T, Hess C, Germak J, Gudermann T, Gruters A 2001 The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 86:4429-4433
9. Corvilain B, Van Sande J, Dumont JE, Vassart G 2001 Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55:143-158
10. de Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E, Misrahi M 1996 A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81:2023-2026
11. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401
12. Esapa CT, Duprez L, Ludgate M, Mustafa MS, Kendall-Taylor P, Vassart G, Harris PE 1999 A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis. Thyroid 9:1005-1010
13. Ferrara AM, Capalbo D, Rossi G, Capuano S, Del Prete G, Esposito V, Montesano G, Zampella E, Fenzi G, Salerno M, Macchia PE 2007 A new case of familial nonautoimmune hyperthyroidism caused by the M463V mutation in the TSH receptor with anticipation of the disease across generations: a possible role of iodine supplementation. Thyroid 17:677-680
14. Fuhrer D, Wonerow P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238
15. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T 1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431-1436
16. Holzapfel HP, Wonerow P, von Petrykowski W, Henschen M, Scherbaum WA, Paschke R 1997 Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 82:3879-3884
17. Karges B, Krause G, Homoki J, Debatin KM, de Roux N, Karges W 2005 TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J Endocrinol 186:377-385
18. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G 1995 Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 332:150-154
19. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281->isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639
20. Lee YS, Poh L, Loke KY 2002 An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism. J Pediatr Endocrinol Metab 15:211-215
21. Nwosu BU, Gourgiotis L, Gershengorn MC, Neumann S 2006 A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism. Thyroid 16:505-512
22. Pohlenz J, Pfarr N, Kruger S, Hesse V 2006 Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R). Acta Paediatr 95:1685-1687
23. Schwab KO, Sohlemann P, Gerlich M, Broecker M, Petrykowski W, Holzapfel HP, Paschke R, Gruters A, Derwahl M 1996 Mutations of the TSH receptor as cause of congenital hyperthyroidism. Exp Clin Endocrinol Diabetes 104(Suppl 4):124-128
24. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554
25. Tonacchera M, Agretti P, Rosellini V, Ceccarini G, Perri A, Zampolli M, Longhi R, Larizza D, Pinchera A, Vitti P, Chiovato L 2000 Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid 10:859-863
26. Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT, Ellard S 2004 Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol (Oxf) 60:711-718
27. Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J, Ludgate M 2000 Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 10:1035-1041
28. Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De Leener A, Vassart G, Costagliola S 2008 A family with a novel TSH receptor activating germline mutation (p.Ala485Val). Eur J Pediatr 167:1231-1237
29. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Fuhrer D 2005 Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism. Thyroid 15:1089-1094
30. Elgadi A, Arvidsson CG, Janson A, Marcus C, Costagliola S, Norgren S 2005 Autosomal-dominant non-autoimmune hyperthyroidism presenting with neuromuscular symptoms. Acta Paediatr 94:1145-1148
31. Khoo DH, Parma J, Rajasoorya C, Ho SC, Vassart G 1999 A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. J Clin Endocrinol Metab 84:1459-1462
32. Leclere J, Thomas JL 1982 [Diffuse nonautoimmune hyperthyroidism]. Ann Endocrinol (Paris) 43:553-568
33. Leclere J, Bene MC, Duprez A, Faure G, Thomas JL, Vignaud JM, Burlet C 1984 Behaviour of thyroid tissue from patients with Graves' disease in nude mice. J Clin Endocrinol Metab 59:175-177
34. Nishihara E, Nagayama Y, Amino N, Hishinuma A, Takano T, Yoshida H, Kubota S, Fukata S, Kuma K, Miyauchi A 2007 A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism. Endocr J 54:927-934
35. Ringkananont U, Van Durme J, Montanelli L, Ugrasbul F, Yu YM, Weiss RE, Refetoff S, Grasberger H 2006 Repulsive separation of the cytoplasmic ends of transmembrane helices 3 and 6 is linked to receptor activation in a novel thyrotropin receptor mutant (M626I). Mol Endocrinol 20:893-903
36. Schwab KO, Gerlich M, Broecker M, Sohlemann P, Derwahl M, Lohse MJ 1997 Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 131:899-904
37. Thomas JS, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC 1982 Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh) 100:512-518
38. Chester J, Rotenstein D, Ringkananont U, Steuer G, Carlin B, Stewart L, Grasberger H, Refetoff S 2008 Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene. J Pediatr Endocrinol Metab 21:479-486
39. Fuhrer D, Mix M, Willgerodt H, Holzapfel HP, von Petrykowski W, Wonerow P, Paschke R 1998 Autosomal dominant nonautoimmune hyperthyroidism. Clinical features-diagnosis-therapy. Exp Clin Endocrinol Diabetes 106(Suppl 4):S10-S15
40. Brown RS, Shalhoub V, Coulter S, Alex S, Joris I, De Vito W, Lian J, Stein GS 2000 Developmental regulation of thyrotropin receptor gene expression in the fetal and neonatal rat thyroid: relation to thyroid morphology and to thyroid-specific gene expression. Endocrinology 141:340-345
41. De Felice M, Di Lauro R 2004 Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25:722-746
42. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R 2002 Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 99:15462-15467
43. van Staveren WC, Weiss Solis D, Delys L, Venet D, Cappello M, Andry G, Dumont JE, Libert F, Detours V, Maenhaut C 2006 Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis. Proc Natl Acad Sci USA 103:413-418
44. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
45. Laurent E, Van Sande J, Ludgate M, Corvilain B, Rocmans P, Dumont JE, Mockel J 1991 Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J Clin Invest 87:1634-1642
46. Roger P, Taton M, Van Sande J, Dumont JE 1988 Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 66:1158-1165
47. Costa MJ, Senou M, Van Rode F, Ruf J, Capello M, Dequanter D, Lothaire P, Dessy C, Dumont JE, Many MC, Van Sande J 2007 Reciprocal negative regulation between thyrotropin/3′,5′-cyclic adenosine monophosphate-mediated proliferation and caveolin-1 expression in human and murine thyrocytes. Mol Endocrinol 21:921-932
48. Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B, Salmon I, Franc B, Dumont JE, Van Sande J, Maenhaut C 2000 Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid 10:131-140
49. Deleu S, Savonet V, Behrends J, Dumont JE, Maenhaut C 2002 Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinomas. Exp Cell Res 279:62-70
50. Eszlinger M, Krohn K, Berger K, Lauter J, Kropf S, Beck M, Fuhrer D, Paschke R 2005 Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90:1163-1170
51. Eszlinger M, Krohn K, Beck M, Kipling D, Forbes-Robertson S, Lauter J, Toenjes A, Wynford-Thomas D, Paschke R 2006 Comparison of differential gene expression of hot and cold thyroid nodules with primary epithelial cell culture models by investigation of co-regulated gene sets. Biochim Biophys Acta 1763:263-271
52. Murakami M, Araki O, Hosoi Y, Kamiya Y, Morimura T, Ogiwara T, Mizuma H, Mori M 2001 Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 142:2961-2967
53. Goffard JC, Jin L, Mircescu H, Van Hummelen P, Ledent C, Dumont JE, Corvilain B 2004 Gene expression profile in thyroid of transgenic mice overexpressing the adenosine receptor 2a. Mol Endocrinol 18:194-213
54. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA 2003 DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:3
55. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA 2003 Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70
56. Van Sande J, Lamy F, Lecocq R, Mirkine N, Rocmans P, Cochaux P, Mockel J, Dumont JE 1988 Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′,5′-monophosphate metabolism. J Clin Endocrinol Metab 66:570-579
57. Deleu S, Pirson I, Coulonval K, Drouin A, Taton M, Clermont F, Roger PP, Nakamura T, Dumont JE, Maenhaut C 1999 IGF-1 or insulin, and the TSH cyclic AMP cascade separately control dog and human thyroid cell growth and DNA synthesis, and complement each other in inducing mitogenesis. Mol Cell Endocrinol 149:41-51
58. Roger PP, Dumont JE, Boeynaems JM 1984 Lack of prostaglandin involvement in the mitogenic effect of TSH on canine thyroid cells in primary culture. FEBS Lett 166:136-140
59. Mantovani A, Allavena P, Sica A, Balkwill F 2008 Cancer-related inflammation. Nature 454:436-444
60. Imaizumi M, Ashizawa K, Neriishi K, Akahoshi M, Nakashima E, Usa T, Tominaga T, Hida A, Sera N, Soda M, Fujiwara S, Yamada M, Maeda R, Nagataki S, Eguchi K 2008 Thyroid diseases in atomic bomb survivors exposed in utero. J Clin Endocrinol Metab 93:1641-1648
61. De Deken X, Vilain C, Van Sande J, Dumont JE, Miot F 1998 Decrease of telomere length in thyroid adenomas without telomerase activity. J Clin Endocrinol Metab 83:4368-4372
62. Krohn K, Wohlgemuth S, Gerber H, Paschke R 2000 Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. J Pathol 192:37-42